NJU Physicians Selected as New Jersey Monthly 2020 Top Doctors

We’re proud to announce that 16 New Jersey Urology physicians have been honored as 2020 Jersey Choice Top Doctors by New Jersey Monthly Magazine.

More than 25,000 New Jersey–based doctors were invited to recommend the physicians they would choose to treat their own family members.

2020 Jersey Choice Top Doctors in Urology:

See New Jersey Monthly’s complete list here >

New Jersey Urology Epic EHR

New Jersey Urology is the First-Ever Urology Group to Launch Epic’s Electronic Health Record

5 Oct 2020 News ,

Bloomfield, NJ, October 5, 2020 – New Jersey Urology (“NJU”), the leading urology service provider in New Jersey, and Urology Management Associates (“UMA”), NJU’s administrative practice management, are pleased to announce the launch of its urologic-centric Epic electronic health record. NJU is the first urology-only group to launch Epic.

“As one of our key strategic priorities for NJU, we are proud to launch the first-ever instance of Epic that was designed, configured, and tailored to address the specialized [specific] workflows of urologic care,” said Scott Ciccarelli, CEO of NJU. “Our unique collaboration with Epic will help us to redefine clinical standards of excellence and will improve urological patient care across the nation.”

“Patients are best served when physician specialists have access to their patients’ full health history,” said Jeff Trinkl, MD, Director of Clinical Informatics at Epic. “As an example, when treating specific conditions, like prostate cancer, urologists need access to other information that could affect the course of care, such as a patient’s medications and underlying health conditions. In Epic, specialty-specific information and the broader picture of a person’s health is all in one place.”

Epic is ranked as the #1 Overall Software Suite by KLAS, an independent healthcare IT research firm. Over 250 million patients worldwide have a health record in Epic. The integrated system pulls together data from NJU’s four legacy systems into one single, merged view within NJU’s 60+ practices across New Jersey and Pennsylvania.

As one of the key drivers of becoming a more patient-centric organization, NJU is also using Epic’s patient-facing app, MyChart. Patients can use MyChart to connect with their care team, view their health record, update their demographic and clinical information, request prescription refills and more. This will vastly improve patient accessibility, increasing patient engagement and satisfaction. Amid the COVID-19 pandemic, this offers patients a safer, simplified and much more streamlined contactless check-in process.

“NJU will now have a toolset designed to treat urological conditions and meet the unique needs of their patients,” said Leela Vaughn, Epic Vice President. “As the first large, independent urology group to install Epic on its own, NJU is creating a new option for other independent urology practices to get Epic and benefit from NJU’s expertise.”

“We selected Epic because it allows NJU to perform under one integrated platform. It supports seamless workflows, efficient coordination, and built-in analytics to improve operational efficiencies,” said Derek Grimes, CIO of NJU. “We began our Epic project back in June 2019, and this launch represents a significant milestone. In partnership with Epic, this initiative is a testament to our amazing NJU Epic team consisting of IT, clinicians, physician champions and Epic Super Users across the entire organization. Epic will revolutionize and transform the daily interactions within our practices, facilitate better patient care, and vastly improve patient outcomes.”

OFFICIAL PRESS RELEASE

 

For more information, contact:

Kathy Meyer
New Jersey Urology, LLC
kmeyer@njurology.com
(973) 453-5652
www.njurology.com

 

###

 

About New Jersey Urology:
NJU is the largest urology practice in the United States. The practice provides complete urologic care and comprehensive individualized treatment at more than 60 convenient locations, including six state-of-the-art Cancer Treatment Centers. Utilizing the latest technology and techniques in the industry, NJU offers advanced urologic care with a personal touch.

About Urology Management Associates:
Urology Management Associates was formed to provide administrative services to New Jersey Urology. UMA enables NJU to continue to focus on providing world-class urology services while remaining a physician-led organization. UMA plans to partner with additional urology groups to provide administrative practice management services in the greater New York metropolitan area with long-term plans to expand nationally.

NJU Physicians Selected as SJ Mag 2020 Top Docs

From sjmagazine.net: “At a time when South Jersey needed medical professionals the most, they showed up. That’s what superheroes do. They do what’s right, and they help people. Because of that, this year’s Top Docs list has taken on new meaning.”

Congratulations to our New Jersey Urology physicians for their selection as Top Doctors in the September 2020 issue of SJ Magazine! Learn more about each ‘top doc’ by clicking on their name below:

Read the complete list here >

Dr. Sanjay Kasturi Designated as Urolift® Center of Excellence

We’re proud to announce that the New Jersey Urology office of Dr. Sanjay Kasturi in Vineland, NJ, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Kasturi has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Sanjay Kasturi as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift System
The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology
A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Public Statement from NJU

Public Statement from New Jersey Urology

26 Jul 2020 News

New Jersey Urology (NJU) is devastated and heartbroken by the tragic incident that occurred at our Mount Laurel office on Friday, July 24, 2020. A patient’s family member​ fatally shot our dear colleague and friend, Stephanie Anne Horton, a patient service representative at the Mount Laurel office, and wounded a waiting patient. The suspect has been charged and is currently in custody.

Stephanie Anne Horton, Beloved friend and colleague“In light of recent events, we have all been going through unspeakable grief and shock in hearing of Stephanie Horton’s passing from this horrific, senseless act of gun violence,” said Scott Ciccarelli, CEO of New Jersey Urology. “We would like to extend our heartfelt condolences and prayers to Stephanie’s family, colleagues and friends. Words can’t express the deep sorrow for the loss of our dear NJU colleague. She will always be remembered fondly as a true friend and loyal employee, and a selfless, courageous hero. Stephanie will leave a special place in our hearts.“

During the shooting, one of our patients was injured from a gunshot wound to her right knee. Her NJU urologist, along with a fellow patient, were at her side until paramedics arrived. She was taken to Cooper University Hospital where she was treated immediately for reconstructive surgery. We are so saddened that she was a victim in this random act of violence, and sincerely hope for her speedy recovery.

This has been such a difficult and traumatic experience, and we can’t put into words how saddened and heartbroken we are feeling right now. We understand that many employees, especially those in the Mount Laurel office, are struggling with the shock and pain from this senseless tragedy. We are providing ongoing grief counseling as needed to provide some comfort and help towards the path of healing.

We have also reached out to patients who were unfortunate witnesses to this heinous and cowardly act of violence. It is our utmost priority that employees and patients feel safe and protected. Additional security presence has been deployed at the Mount Laurel office parking area and building, and we are currently assessing other security measures for all our practices.

In remembrance of Stephanie Horton, we will be lowering flags at all of our NJU facilities (those with flags) at half-staff on Monday, August 3rd.

NJU would like to extend our sincere thanks for the outpouring of support we have received from all of our NJU offices, and many national and local organizations. We are deeply touched by their thoughtfulness and support during this difficult time.

Thank you from NJU:

Advanced Urology Institute
American Urological Association
Chesapeake Urology
City of Hope Surgery
Connecticut Children’s Hospital
Fraternal Order of Police Mt. Laurel Lodge 191
iSalus Healthcare
Jefferson Health
Jersey Urology
LUGPA
Macs Janitorial
Mayo Clinic
Mid Atlantic Stone Center Atlantic Lithotripsy, LLC
Mount Laurel Fire Department
Mount Laurel Police Department
Neotract / Teleflex
North Carolina Cancer Hospital
Phreesia Inc.
Rancocas Anesthesiology
ReclaimAbility Pain Services
Red Lanterns Farms LLC
Specialty Networks (UroGPO)
Street Road Animal Hospital
The Center for Kidney Care
The Stone Center of NJ
United Urology
Virtua Mt. Laurel Family Physicians
Virtua Surgical and Breast Group of Moorestown Virtua
Zamir Equities
ZERO Cancer

____________

Updated August 4, 2020
The GoFundMe page is now closed. For Stephanie Horton created by coworkers on behalf of her family:  https://gf.me/u/yifx5h.

new york magazine best doctors 2020

New York Magazine Names New York Metro Area’s Best Doctors 2020

We are proud to announce that 33 New Jersey Urology physicians have been honored as New York Magazine’s 2020 Best Doctors in Urology.

The New York Metro Area is home to some of the most prominent and sought after physicians in the country. New York Magazine works with Castle Connolly Medical Ltd., a New York City-based research and information company, who selects the top 10 percent of the region’s physicians by conducting a peer-reviewed survey. Licensed physicians vote for the doctors they view as exceptional, and the Castle Connolly physician-led research team tabulates the results and vets the nominee pool, confirming the doctors’ board certifications and licensing, and investigating their disciplinary histories.

Congratulations to our esteemed urologists from our multiple locations right here in New Jersey!

 

2020 NEW YORK MAGAZINE BEST DOCTORS (Full List):

Mutahar Ahmed, MD
Andrew Bernstein, MD
Rahuldev Bhalla, MD
Thomas Christiano, MD
Thomas Chun, MD
Michael Esposito, MD
Mark Fallick, MD
Joshua Fiske, MD
Glen Gejerman, MD
Martin Goldstein, MD
Steven Katz, MD
George Klafter, MD
Vincent Lanteri, MD
Bernard Lehrhoff, MD
Gregory Lovallo, MD
Daniel Lowe, MD
Eric Margolis, MD
Mark Miller, MD
Thomas Mueller, MD
Marcella Nachmann, MD
Adam Perzin, MD
Ravi Rajan, MD
Steven L. Richards, MD
Kenneth Ring, MD
Gene Rosenberg, MD
Hossein Sadeghi-Nejad, MD
Frank Salvatore, MD
Domenico Savatta, MD
Eric Seaman, MD
Andrew Siegel, MD
Robert B. Simon, MD
Alan Strumeyer, MD
Gary Wasserman, MD

 

The complete list of NJU Best Doctors can be viewed here  >

Philadelphia Magazine Top Doctors 2020

NJU Physicians Selected as Philadelphia Magazine 2020 Top Doctors

4 May 2020 News

We’re proud to announce that five New Jersey Urology physicians have been honored as Philadelphia Magazine 2020 Top Doctors in Urology. These physicians were nominated by their peers as the very best in their field, and were carefully screened and vetted for educational and professional experience before being selected.

Philadelphia Magazine 2020 Top Doctors:

View Philadelphia Magazine’s complete list of Top Doctors > https://bit.ly/2xYmooI 

Telemedicine

Introducing Telemedicine Services for Our Patients

We are all living in unprecedented times, and understand why you may have missed or cancelled your scheduled appointment. Please know that it is also extremely important to us that you continue to receive the care you need even during this difficult time.

With this in mind, New Jersey Urology (NJU) has developed a solution that protects both our patients and our staff. As an alternative to an in-person office visit, NJU is now offering telemedicine services effective immediately. Telemedicine can be done through the comfort of your home allowing your physician to provide a “virtual” visit through your phone or computer.

The Centers for Medicare & Medicaid Services have broadened access to Medicare telemedicine services, and major insurance companies have waived referrals and copay fees and obligations. Please check with your insurance provider as it relates to your individual situation.

“New Jersey Urology is excited to offer the convenience of telemedicine services to our patients. We want to empower our patients and give them the tools they need to manage their health amid the fluid situation we are all experiencing with the COVID-19 threat,” said Scott Ciccarelli, CEO of NJ Urology.

What You Need To Know

  • To limit the exposure of COVID-19, the Centers for Medicare & Medicaid Services (CMS) have broadened access to Medicare telemedicine services.

  • Major insurance companies have waived referrals and copay fees and obligations for telemedicine services (co-pay for other services will still apply).

How To Schedule a Virtual Visit

Call to schedule an appointment and inform the doctor’s office that you are interested in scheduling a virtual visit. You will receive email instructions to get set up. It’s that simple!

We will continue to provide best-in-class urologic care for our patients while taking preventative measures to help contain the community spread of this virus. Together, we will get through these challenging times.

Please contact us to learn more about our telehealth services.

Be well and stay safe!


Bergen County Top Docs 2020

Bergen Magazine Names Bergen County’s Top Docs 2020

We are proud to announce that 7 New Jersey Urology physicians have been honored as 2020 Bergen County’s Top Doctors by BERGEN Magazine.

Bergen County is home to some of the most prominent and sought-after physicians in the country. BERGEN magazine commissioned Professional Research Services (PRS) of Troy, Michigan to select the finalists. All final honorees were fact-checked with the State of New Jersey and the New Jersey Division of Consumer Affairs License Verication System.

Congratulations to our esteemed urologists from our Englewood, and Maywood / Teaneck locations!

 

2020 BERGEN COUNTY’S TOP DOCS:

See BERGEN Magazine’s complete list of Urology doctors here >

Dr. Adam Perzin Designated as Urolift® Center of Excellence

18 Feb 2020 News

We’re proud to announce that the New Jersey Urology office of Dr. Adam Perzin in Burlington County has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Perzin has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“Dr. Perzin has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit.

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift System
The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at www.UroLift.com.

About NeoTract | Teleflex Interventional Urology
A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at www.NeoTract.com.

About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit www.teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

1 2 3 4

Search

+
Skip to content